Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Arthroscopic stabilization for anterior shoulder instability with subcritical glenoid bone loss

Official title: Arthroscopic Stabilization of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss: A Comparison Between Dynamic Anterior Stabilization and the Latarjet Procedure

Run by Clinique Générale dAnnecy · NCT07715162 · Data updated 2026-11-12

This study tests two arthroscopic stabilization methods to help people with recurrent anterior shoulder instability and subcritical glenoid bone loss see if they achieve better stability.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment84 (estimated)
SponsorClinique Générale dAnnecy
Academic / other
Locations1 site (Annecy)
StatusRecruiting
StartedSeptember 3, 2026
Main results expectedNovember 1, 2030
Study endsNovember 1, 2030
Registry record updatedSeptember 10, 2026
Trial IDNCT07715162 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18+ with symptomatic recurrent anterior shoulder instability and subcritical glenoid bone loss (~13.5–20%), with HAGL lesions and bone lesions, capable of consenting and completing 24 months of follow-up.

Probably not a fit

Individuals with glenoid bone loss >20%, indications for a different procedure, prior bone stabilization, certain rotator cuff or neurologic conditions, or inability to follow up may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients aged 18 or older with recurrent, symptomatic anterior shoulder instability and subcritical glenoid bone loss (about 13.5% to 20%) undergo either arthroscopic Latarjet stabilization or dynamic anterior stabilization (DAS). The trial compares these surgical approaches in a real-world setting with typical associated lesions to determine which technique provides better joint stability and functional outcomes over 24 months. Outcomes likely include recurrence of instability, shoulder function, and patient-reported measures, with follow-up planned to assess durability. The protocol emphasizes careful patient selection, imaging-based bone loss classification, and management of associated lesions such as HAGL and Hill-Sachs lesions. The trial is conducted at Clinique Générale dAnnecy with no listed collaborators beyond the lead sponsor.

Why it matters

Potential benefit: If successful, participants could experience improved shoulder stability and function after surgery, reducing recurrence.

How similar studies have gone: Prior data suggest subcritical bone loss presents treatment challenges; this trial tests whether arthroscopic Latarjet or DAS can improve outcomes in this group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* aged 18 or older
* with symptomatic recurrent anterior shoulder instability indicating the need for surgical stabilization
* whose glenoid bone loss must be classified as subcritical, approximately between 13.5% and 20%, according to the criteria defined in the protocol
* with HAGL lesions
* with bone lesions
* capable of providing informed consent and complying with the planned 24-month follow-up

Exclusion Criteria:

* with glenoid bone loss exceeding 20%
* with a clear indication for another procedure not covered by the protocol (particularly if routine bone grafting is required and incompatible with the study)
* with a history of bone stabilization of the affected shoulder
* with a transfixing rotator cuff tear or a neurological condition impairing shoulder function
* unable to guarantee adequate follow-up
* under legal guardianship (curatorship, guardianship, or judicial protection)
* deprived of liberty by judicial or administrative order
* receiving psychiatric care
* not enrolled in a social security program

Where it's running

  • Clinique Générale d'Annecy
    Annecy, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.